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ABSTRACT  The small GTPase Ras acts as a master regulator of growth, stress 
response and cell death in eukaryotic cells. The control of Ras activity is fun-
damental, as highlighted by the oncogenic properties of constitutive forms of 
Ras proteins. Ras also plays a crucial role in the pathogenicity of fungal patho-
gens where it has been found to regulate a number of adaptions required for 
virulence. The importance of Ras in fungal disease raises the possibility that it 
may provide a useful target for the development of new treatments at a time 
when resistance to available antifungals is increasing. New findings suggest 
that important regulatory sequences found within fungal Ras proteins that 
are not conserved may prove useful in the development of new antifungals. 
Here we review the roles of Ras protein function and signalling in the major 
human yeast pathogens Candida albicans and Cryptococcus neoformans and 
discuss the potential for targeting Ras as a novel approach to anti-fungal 
therapy. 
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RAS PROTEINS ʹ FORM AND FUNCTION 
The Ras superfamily consists of small G-binding proteins 
that have been divided into five main groups on the basis 





As with all G proteins, Ras activation is 
dependent on the exchange of bound GDP for GTP and 
deactivation via hydrolysis of GTP to GDP. Cycling between 
active and non-active states is regulated by Guanine nucle-
ŽƚŝĚĞĞǆĐŚĂŶŐĞ ĨĂĐƚŽƌƐ  ?'& ? ?ĚŝƐƐŽĐŝĂƚŝŽŶ ŝŶŚŝďŝƚŽƌ ?Ɛ  ?'/ ?
and GTPase Activating Proteins (GAP) accessory proteins 
[2]. The activation and deactivation cycle of Ras proteins 
couple a range of stimuli to effector proteins and as such 
these G-ƉƌŽƚĞŝŶƐ ƐĞƌǀĞ ĂƐ ƌĞŐƵůĂƚŽƌǇ  “ƐǁŝƚĐŚĞƐ ? ǁŝƚŚŝŶ Ă
variety of cellular processes. The importance of Ras signal-
ling is highlighted by the dramatic effects that can be ob-
served upon inappropriate activation. For example muta-
tions that lead to the constitutive activation of Ras signal-
ling have been estimated to occur in ~50% of all tumours 
[3]. In addition, Ras proteins play important roles in the 
regulation of growth and adaption in fungal cells. In this 
review we will focus on Ras protein function in the major 
human yeast pathogens Candida albicans (C. albicans) and 
Cryptococcus neoformans (C. neoformans). 
RAS SIGNALLING IN THE FUNGAL PATHOGEN OF HU-
MANS C. ALBICANS 
C. albicans virulence and pathogenicity 
C. albicans is a commensal organism that is commonly 
found on the mucosal surfaces of the oral cavity, gastroin-
testinal tract and genitourinary tract of healthy individuals 
[4, 5]. However C. albicans is also a well characterised op-
portunistic pathogen [4, 6] and a serious health-risk 
amongst immunocompromised individuals, such as those 
suffering from HIV infection, or persons living with indwell-
ing medical devices such as catheters or voice prostheses 
[7, 8]. The infections caused by C. albicans range from su-
perficial infection of mucosal and non-mucosal surfaces 
(candidiasis) to a full systemic infection (candidaemia) also 
affecting internal organs
 
[4]. Superficial mucosal surface 
infections can be readily treated with a range of antifun-
gals. For example, vulvovaginal candidiasis (VVC) is usually 
successfully treated with azole antifungals like fluconazole 
[9]. However, candidaemia is associated with a high mortal-
ity even when treated with a variety of classes of antifun-
gal agents [10]. As with many C. albicans infections, weak-
ened immune defences are a significant risk factor for de-
veloping candidaemia. In healthy individuals, neutrophils 
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provide suitable defence against C. albicans. As such, neu-
tropenia, either as a result of particular blood cancers or 
treatment with immunosuppressants, significantly increas-
es the risk of developing candidaemia. Furthermore, dam-
age to the mucosa of the gastrointestinal tract, for exam-
ple due to surgery, is also a risk factor as it enables the 
spread of C. albicans [11]. The symptoms of candidaemia 
range from fever and chills which do not abate following 
antibiotic treatment to severe sepsis or septic shock similar 
to that of bacterial septicaemia [9]. However, a lack of pre-
cise symptoms can lead to delayed diagnosis and required 
antifungal treatment leading to increased mortality [12]. It 
has been reported that even a delay of as little as 12-24h 
can double mortality rate
 
[13]. Due to this, it has been sug-
gested to prophylactically administer antifungals after any 
event which is likely to increase the risk of candidaemia, 
such as after abdominal surgery or bone marrow trans-
plant [9]. Although the majority of cases of candidiasis and 
candidaemia are caused by C. albicans, there are other 
species within the Candida genus which are also pathogen-
ic in humans. These include Candida glabrata, Candida 
tropicalis, Candida dubliniensis and Candida parapsilosis.  
Candida species have increasingly become associated with 
nosocomial infections [6]; in fact, C. albicans is recognised 
as the fourth most common cause of all hospital-acquired 
infections in the USA [4]. 
 
Morphogenesis, pathogenicity and Ras signalling in C. 
albicans 
An important aspect of C. albicans biology, in terms of 
pathogenesis, is its ability to undergo morphogenesis from 
a yeast, to pseudohyphal or hyphal forms in response to 
environmental cues. The virulence of C. albicans is closely 
linked with the capacity to switch between these forms. 
Hyphal C. albicans cells are frequently located at sites of 
tissue invasion, moreover, cells which are unable to readily 
form hyphae exhibit reduced virulence [4]. However as 
strains that are incapable of growing in the yeast form also 
have less virulence it has been proposed that both the 
yeast and hyphal forms play important roles during infec-
tion [14, 15]. Ras signalling is crucial to the integration of 
environmental cues with morphogenesis and C. albicans 
possesses two Ras genes - RAS1 and RAS2, which encode 
the Ras1 protein and a highly divergent Ras-like protein 
termed Ras2 [16]. The importance of Ras1 signalling to the 
virulence of C. albicans is demonstrated by the fact that 
mutants which lack Ras1 are defective in their ability to 
undergo hyphal transition and exhibit reduced virulence in 
mouse infection models [17]. Ras signalling is now known 
to mediate the induction of hyphal growth in response to a 
variety of environmental cues including growth at 37
°
C (via 
alleviation of Hsp90-mediated repression of the Ras1-
cAMP-PKA pathway) [18, 19], exposure to high levels of 
CO2 [20], N-acetylglucosamine [21] and serum exposure 
[22]. These environmental signals are transduced through 
the cyclic AMP-protein kinase A and a mitogen-activated 
protein (MAP) kinase pathways (Figure 1) [4]. These path-
ways culminate in the regulation of transcription factors 
which control the expression of hyphal-specific genes 
(HSGs) such as Als3 (adhesin) [23], Hwp1 (invasin) [24], 
Hyr1 (host immune response modulator) [25], and Hgc1 
(hyphal-specific cyclin) [26].  
Upon activation, Ras1 directly interacts with and acti-
vates Cyr1 (the C. albicans adenylate cyclase), causing an 
increase in the production of the second messenger cAMP 
[17]. cAMP causes the derepression of two isoforms of 
protein kinase A (PKA) by triggering the dissociation of the 
PKA regulatory subunit (Bcy1) from the catalytic subunits 
(Tpk1 or Tpk2). The activation of PKA stimulates several 
processes within the cell including the yeast-to-hyphae 
switch [27]. PKA is believed to phosphorylate the transcrip-
tion factor Efg1 on threonine-206, thereby activating it and 
resulting in the expression of HSGs [28]. The Tpk1 and Tpk2 
isoforms have some redundant functions in C. albicans, 
however, they also have specific roles in filamentation. For 
example, Tpk1 is necessary for the expression of genes 
encoding proteins involved in branched chain amino acid 
biosynthesis, and Tpk2 negatively regulates iron uptake 
genes and positively regulates those associated with treha-
lose degradation and water homeostasis [29].  
A number of environmental signals promote the yeast-
to-hyphae switch via the Ras1-Cyr1-PKA pathway. Some of 
these signals, including CO2 interface directly with the Cyr1 
adenylate cyclase to activate it [20]. CO2 is able to do this 
because, unlike most signalling molecules, it is able to en-
ter the cell by simple diffusion and is maintained in the cell 
as HCO3
-
 via conversion by a carbonic anhydrase encoded 
by NCE103 [20]. It has recently been discovered that the 
expression of NCE103 is controlled in response to CO2 
availability by the bZIP transcription factor Rca1; Rca1 is 
regulated in a CO2-dependent manner by the Sch9 kinase 
via a cascade mediated by lipid/Pkh1/2 signalling [30]. A 
lysine residue at position 1373 is critical for CO2 activation 
of Cyr1. This lysine residue is located in the C-terminal 





[31], leading to increased 
cAMP production and activation of PKA filamentation [20]. 
The response of C. albicans to CO2 is of interest because 
within a mammalian host, the levels of CO2 are approxi-
mately 150x that of normal air (~5% compared to 0.03%). It 
may be the case that high levels of CO2, such as are found 
within the upper respiratory tract, may promote C. albi-
cans colonisation.
 
However, it is interesting to note that 
other pathogenic Candida species, including C. dubliniensis, 
C. glabrata, C. paropsilosis and C. krusei, do not undergo 
the yeast-to-hyphae transition in response to elevated CO2 
[20]. Although this does not rule out the fact that the ade-
nylyl cyclase of the latter species is activated by carbon 
dioxide/bicarbonate; the physiological significance of CO2 
sensing with regards to Candida infection remains to be 
determined.  
Muramyl dipeptide (MDP), the minimal biologically ac-
tive subunit of bacterial peptidoglycan, also induces C. al-
bicans filamentation by acting directly upon Cyr1 [32]. A 
further signal which can cause morphogenesis through 
direct interaction with Cyr1 are amino acids. Amino acids, 
when in the presence of glucose, activate Cyr1 via up-
stream  signalling through the G-protein  coupled  receptor  
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Gpr1 and ŝƚƐ'ɲƉƌŽƚĞŝŶ'ƉĂ2 [33]. Upon its activation by 
'Ɖƌ ? ?'ƉĂ ?ŝƐďĞůŝĞǀĞĚƚŽďŝŶĚƚŽĂ'ɲĚŽŵĂŝŶŽŶƚŚĞǇƌ ?
adenylate cyclase thereby activating it [33]. This binding of 
'ƉĂ ? ƚŽ Ă ĨƵŶŐĂů ĂĚĞŶǇůĂƚĞ ĐǇĐůĂƐĞ 'ɲ ĚŽŵĂŝŶ ŚĂƐ ďĞĞŶ
demonstrated in fission yeast
 
[34] but it is yet to be proved 
experimentally in C. albicans.   
In contrast, acidic pH causes a reduction in signalling 
through the Ras1-Cyr1-PKA pathway via a Ras1-
independent downregulation of Cyr1 activity [35]. C. albi-
cans cells grown at pH 4 in hyphae-inducing conditions do 
not form hyphae, instead remaining as yeast or pseudohy-
phal cells and this is not reliant upon Ras1. It has also been 
observed that low extracellular pH results in fast and sus-
tained decreases in intracellular pH which potentially con-
tributes to reduced cAMP signalling through the reduction 
of intracellular bicarbonate levels [35].      
The yeast-to-hyphae switch in response to exposure to 
serum relies on Ras1 signalling upstream of Cyr1 [22]. The 
component of serum principally responsible for the induc-
tion of hyphal growth is D-glucose which is able to activate 
both the Ras1-Cyr1-PKA pathway and the MAP-kinase 
pathway [22, 36]. The precise mechanism of Ras1 activa-
tion by D-glucose in C. albicans remains to be elucidated 
but in Saccharomyces cerevisiae (S. cerevisiae) it depends 
on both an intracellular phosphorylated form of D-glucose 
and a G-ƉƌŽƚĞŝŶĐŽƵƉůĞĚƌĞĐĞƉƚŽƌ'Ɖƌ ?ǁŝƚŚŝƚƐ'ɲƉƌŽƚĞŝŶ
Gpa2 [37]. Gpr1-type receptors have been characterised in 
C. albicans [33] and so a similar mechanism for Ras1 activa-
tion may exist in this pathogen. However, deletion of ei-
ther CaGpr1 or CaGpa2 had no effect on D-glucose-
mediated cAMP signalling, but deletion of CaCdc25 (the C. 
albicans Ras1 GEF) or CaRas1 eliminated this signalling [33]. 
These findings indicate Ras1 activation via Cdc25 is the 
primary mechanism by which D-glucose induces morpho-
genesis. The response of C. albicans to D-glucose is of phys-
iological relevance because links between candida infec-
tion and hyperglycaemia
 
[38] as well as insulin-dependent 
diabetes mellitus
 
[39] have been reported. Moreover, C. 
albicans cells have increased resistance to oxidative and 
cationic stresses upon exposure to levels of glucose that 
may be found in the bloodstream [40].  
FIGURE 1: Summary of the signalling pathways and stimuli which regulate the yeast-to-hyphae morphogenic switch in Candida albicans. 
Several different pathways are responsible for inducing the yeast-to-hyphae switch: MAP kinase pathway (green), Cyr1-PKA pathway (blue), 
pH response pathway (red), and matrix response pathway (orange). There are also two pathways which negatively regulate the switch: 
Tup1-Nrg1-Rpg1 pathway (purple) and Rbf1 pathway (grey). The signalling pathways that engaged in response to different conditions to 
regulate the yeast-to-hyphae morphogenic switch in C. albicans are also indicated. 
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Ras1 has also been shown to regulate hyphal transition 
in response to other environmental cues, such as nitrogen 
starvation [41], via MAP kinase signalling. As with the 
Cyr1/PKA pathway, the regulatory MAP kinase cascade is 
also activated by Ras1 [17] and consist of the kinases Cst20, 
Hst7 and Cek1 [42, 43, 44, 45, 46]. Ras1/MAPK signalling 
culminates in the phosphorylation and activation of the 
transcription factor Cph1, which in turn promotes the ex-
pression of HSGs (Figure 1) [33]. It has been shown that 
inactivation of the Ras1-Cyr1-PKA pathway inhibits fila-
mentous growth in the majority of usual hyphae-inducing 
conditions, however, inactivation of the MAP-kinase path-
way only prevents filamentous growth in only a specific 
subset of conditions [43].  
The CaRas2 protein contains several variations in con-
served motifs typically thought to be critical for Ras-related 
activities and is thus considered an unusual Ras protein. 
Sequence alignment using BLAST has shown that the C. 
albicans Ras2 protein only has 25-30% identity with all 
other fungal Ras proteins in the database except a Ras-like 
protein only found in Candida dubliniensis (80% identity) 
[47]. When RAS2 is deleted in a ras1A?/A? background, intra-
cellular cAMP levels are restored to approximately 30% of 
wild type levels (ras1A?/A? mutant has a 20x reduction in 
cAMP). Ras1 and Ras2 may therefore exhibit antagonistic 
roles in C. albicans [47]. This is intriguing since the deletion 
of RAS2 in a ras1A?/A? background results in a significantly 
increased defect in hyphal morphogenesis. Nevertheless as 
ƌĂƐϮѐ/ѐ mutants themselves exhibit normal hyphal devel-
opment
 
[47] the role of Ras2 in morphogenesis and patho-
genesis in C. albicans has yet to be elucidated.  
In addition to the signalling pathways which drive the 
yeast-to-hyphae switch, there are also negative regulators 
that are controlled by Ras signalling (Figure 1). Hyphal-
specific genes are repressed by the global-repressor Tup1
 
[48] via the specific DNA-binding proteins Nrg1 [49][50] 
and Rfg1 [51]; the deletions of each of these three proteins 
results in C. albicans cells which are constitutively hyphal 
even under non-hyphal inducing conditions [48, 49, 50, 51]. 
Approximately half of the genes found to be upregulated 
during hyphal development in response to 37
°
C and serum 
are repressed by Tup1 and Nrg1 or Rfg1, suggesting that 
repression removal is a crucial step in the yeast-to-hyphae 
switch [52]. Consistently, it has been found that hyphal-
inducing conditions such as serum exposure and growth at 
37
°
C cause a reduction in the expression levels of NRG1, 
leading to the conclusion that one way in which repression 
of hyphal-specific genes is overcome during the yeast-to-
hyphae switch is via down-regulation of the repressors [50]. 
Ras1-Cyr1-PKA pathway activation results in the prompt 
but short-term removal of Nrg1 from the promoters of 
hyphal-specific genes. The maintenance of this repression 
elimination, and hence hyphal development, is achieved 
through the subsequent recruitment of the Hda1 histone 
deacetylase which deacetylates a subunit of NuA4 histone 
acetyltransferase, causing it to also be removed from the 
promoter. This results in the coiling of the portion of the 
promoter containing the Nrg1 binding site, preventing the 
re-binding of Nrg1. It is important to note the removal of 
Nrg1 is an absolute prerequisite for the Hda1 recruitment 
[53]. 
 
Ras signalling and white-opaque switching in C. albicans 
C. albicans was traditionally considered to be asexual, only 
existing as an obligate diploid [54]. However, it has now 
been discovered that mating occurs between homozygous 
diploid mating type-like (MTL) a ĂŶĚɲƐƚƌĂŝŶƐŝŶƚŚŝƐŽƌŐĂn-
ism, producing an a ?ɲ ƚĞƚƌĂƉůŽŝĚ Ɖroduct [54, 55] which 
ƚŚĞŶƵŶĚĞƌŐŽĞƐ ‘ĐŽŶĐĞƌƚĞĚĐŚƌŽŵŽƐŽŵĞůŽƐƐ ?ƚŽĨŽƌŵĚŝp-
loid progeny [56]. C. albicans has also been reported to 
have a viable haploid state which can mate to restore the 
diploid form [57]. While this is similar to the mating pro-
gram in S. cerevisiae (two haploid mating types; a ĂŶĚ ɲ
which combine to generate an a ?ɲĚŝƉůŽŝĚƉƌŽĚƵĐƚ ? [58] it 
differs in several key respects.        
Mating in C. albicans is reliant on a reversible phenotyp-
ŝĐƐǁŝƚĐŚďĞƚǁĞĞŶƚǁŽƐƚĂƚĞƐƚĞƌŵĞĚ ‘ǁŚŝƚĞ ?ĂŶĚ ‘ŽƉĂƋƵĞ ? ?
KŶůǇ ƚŚĞ  ‘ŽƉĂƋƵĞ ? ƐƚĂƚĞ ŝƐ ĐĂƉĂďůĞ ŽĨ ŵĂƚŝŶŐ ĞĨĨŝĐŝĞŶƚůǇ ?
 ‘ŽƉĂƋƵĞ ? ĐĞůůƐ ŚĂǀĞ ďĞĞŶ ĚĞŵŽŶƐƚƌĂƚĞĚ ƚŽ ŵĂƚĞ ĂƉƉƌŽǆi-
mately 10
6
 ĨŽůĚŵŽƌĞƌĞĂĚŝůǇƚŚĂŶ ‘ǁŚŝƚĞ ?ĐĞůůƐ[59] ? ‘tŚŝƚĞ ?
cells are fairly round and form white, dome-shaped colo-
nies on solid agar, they also express a specific set of genes. 
/ŶĐŽŶƚƌĂƐƚ ?  ‘ŽƉĂƋƵĞ ?ĐĞůůƐ ƚĞŶĚƚŽďĞ ůĂƌŐĞƌĂŶĚŵŽƌĞb-
long, forming darker colonies which grow flatter against 
ƐŽůŝĚ ĂŐĂƌ ?  ‘KƉĂƋƵĞ ? ĐĞůůƐ ĂůƐŽ ĞǆƉƌĞƐƐ Ă ƐƉĞĐŝĨŝĐ ƐĞƚŽĨ
genes which differ from those expressed ŝŶ  ‘ǁŚŝƚĞ ? ĐĞůůƐ
[60].     
This unusual mating program involving a reversible phe-
notypic switch hitherto seems to be unique to C. albicans 
as well as the very closely related fungal species C. 
dubliniensis [61] ? /ƚ ĂƉƉĞĂƌƐ ƚŚĂƚ  ‘ǁŚŝƚĞ ? ĐĞůůƐ ĂƌĞ ďĞƚƚĞƌ
suited for growth and survival within a mammalian host. 
Therefore, it is likely this unusual mating program has 
evolved to allow C. albicans to survive the variety of envi-
ronments within a mammalian host while still being able to 
produce mating-competent cells [59].    
Only C. albicans cells which are homozygous at the MTL 
locus (a/a Žƌ ɲ ?ɲ ? ĂƌĞ ĐĂƉĂďůĞ ŽĨ ƌĞǀĞƌƐŝďůǇ ƐǁŝƚĐŚŝŶŐ ďe-
ƚǁĞĞŶ ‘ǁŚŝƚĞ ?ĂŶĚ ‘ŽƉĂƋƵĞ ?ƐƚĂƚĞƐ ?ĂŶĚĂƌĞƚŚƵƐĐĂƉĂďůĞŽĨ
efficient mating [55, 62]. This is because two homeodo-
main proteins called Mtla ? ĂŶĚ Dƚůɲ ? ? ĞŶĐŽĚĞĚ ďǇ ƚŚĞ
MTLa and Dd>ɲ alleles respectively, work together to in-
hibit white-opaque switching [59]. These proteins are both 
present in MTL heterozygous cells (a ?ɲ ? ĂŶĚ ƚŚƵƐ ǁŚŝƚĞ-
opaque switching cannot occur, only one of these two pro-
teins is present in MTL homozygous cells, meaning white-
opaque switching is not suppressed and mating (between 
a/a ĐĞůůƐĂŶĚɲ ?ɲĐĞůůƐ ?ĐĂŶƚĂŬĞƉůĂĐĞ ? 
The transcription factor Wor1 is the master regulator of 
the white-opaque switch and acts in an all-or-nothing 
manner; it is virtually undetectable in white cells but highly 
expressed in opaque cells (expression is approximately 47-
fold higher in opaque cells) [63]. Wor1 has been shown to 
control the expression of its own gene WOR1 in either a 
positive feedback or double-negative feedback loop and 
drives the C. albicans cell into the opaque state [64]. Due 
to WOR1 being repressed by the Mtla ?ĂŶĚDƚůɲ ?ƉƌŽƚĞŝŶƐ
[63], Wor1 is not present in MTL heterozygous cells (a ?ɲ ?
D.R. Pentland et al. (2017)  Ras in pathogenic yeast 
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cells and ectopic WOR1 expression in these cells causes 
them to undergo the white-opaque switch [64].  
The Ras1-Cyr1-PKA pathway is known to have a role in 
the white-opaque switch. High levels of CO2 can induce this 
switch; in 20% CO2 the switch has been reported to occur 
with up to 105x more frequency compared to normal air 
[65]. In a ras1ȴ ?ȴ ŵƵƚĂŶƚ ĂŶĚ Ăcdc35ȴ ?ȴ ŵƵƚĂŶƚ  ?ǁŚŝĐŚ
lacks the CO2-responsive Cyr1 adenylate cyclase) white-
opaque switching is reduced in both normal air and 1% CO2 
compared to wild-type but normal in 20% CO2 [65]. This 
suggests signalling through the Ras1-Cyr1-PKA pathway is 
important for the switch in normal air and moderate CO2 
but not in very high levels of CO2.       
High N-acetylglucosamine levels also induce the white-
opaque switch, and this switch in response to N-
acetylglucosamine is significantly diminished from 
90.5±3.8% cells in the wild-type to 11.2±1.5% in a ras1ȴ ?ȴ
mutant [66]. Likewise, in a cdc35ȴ ?ȴ ŵƵƚĂŶƚ ?  ? ? ?A? ? ? ?A? ŽĨ
cells undergo the white-opaque response in the presence 
of N-acetylglucosamine compared to 86.9±4.3% in the 
wild-type [66]. These results suggest the N-
acetylglucosamine switch occurs via signalling through the 
Ras1-Cyr1-PKA pathway. Furthermore, when the master 
switch regulator Wor1 is overexpressed in a ras1ȴ ?ȴ ?
cdc35ȴ ?ȴ ?tpk1ȴ ?ȴ Žƌtpk2ȴ ?ȴbackground, the cells are 
driven into the opaque state. Conversely, a wor1ȴ ?ȴ ŵu-
tant does not switch in the presence of N-
acetylglucosamine [66]. Wor1 contains a consensus PKA 
phosphorylation motif with a phosphorylatable threonine 
at residue 67 [64], and it has been demonstrated that this 
threonine is absolutely required for white-opaque switch-
ing in response to N-acetylglucosamine [66]. These results 
imply that the transcription factor Wor1 functions down-
stream of the Ras1-Cyr1-PKA pathway to induce white-
opaque switching in the presence of N-acetylglucosamine.         
In addition to Wor1 there are also other transcription 
factors which act as switch regulators, specifically; Efg1 
(itself Ras1-regulated), Czf1, Wor2
 
[67] and Wor3 [68]. 
Binding sites for Wor1 have been identified upstream of 
EFG1, CZF1 and WOR2, indicating that these transcription 
factors function in a regulatory circuit composing positive-
feedback loops with the Ras1-regulated Wor1 in a central 
position [67]. 
 
RAS SIGNALLING AND C. ALBICANS BIOFILM 
FORMATION 
Biofilms are structured communities of microorganisms 
which are attached to either a living or non-living surface. 
The cells are often encased within a matrix of self-made 
extracellular polymeric substance (EPS); this EPS is com-
posed of DNA [69, 70], lipids [69], proteins
 
[69, 71] and 
polysaccharides [69]. Medically, biofilms are of particular 
importance because it is thought that a significant per-
centage of human microbial infections include biofilm for-
mation [72, 73, 74]. Moreover, cells which reside within 
biofilms have distinctive phenotypes compared to plank-
tonic cells, for example, they exhibit increased resistance 
to antibiotic and antifungal drugs. The reasons for this in-
creased resistance are complex but include the presence of 
an extracellular matrix reducing the ability of antimicrobial 
agents to reach the cells, metabolic differences (such as 
modulation of glycolysis, ergosterol biosynthesis and mito-
chondrial respiration)
 
[75] inherent to biofilms and upregu-
lation of efflux pumps [76]. C. albicans biofilms are usually 
composed of a mixture of morphological forms; typically 
yeast, pseudohyphal and true hyphal cells are all present 
within a mature biofilm
 
[6, 77, 78]. The formation of a bio-
film is the result of a very precise and complex series of 
events that are divided into distinct stages; attachment, 
initiation, maturation and dispersal. Biofilm formation is 
therefore complex and highly regulated with more than 
1000 genes found to be upregulated during biofilm devel-
opment [79]. 
Hyphal cells are important for the formation of 
C.albicans biofilms, one reason for this is that the expres-
sion of several cell surface adhesins, such as Hwp1 and 
Eap1, is increased during hyphal growth. These adhesins 
are required for the initial attachment phase of biofilm 
formation, and as a result it means Ras signalling is strongly 
linked to their development [80]. This is highlighted by the 
finding that the hyphal-defective mutant efg1A?/A? is unable 
to form biofilms [81]. Rather than the true basal layer 
which wild-type C. albicans cells form, efg1A?/A? mutants 
produce very few surface-attached cells. Despite this the 
surface-attached mutant cells do display resistance to both 
fluconazole and amphotericin B [81]. These are important 
observations that suggest surface-adhesion is sufficient to 
induce an antifungal resistance response in biofilms [78].  
The transcription factor Bcr1, which is upregulated by 
Tec1 (Figure 1) is an important regulator of C. albicans bio-
film formation. The bcr1A?/A? mutant is unable to form bio-
films and also cannot switch to hyphal growth under cer-
tain conditions. However, when present within mixed bio-
films formed using wild-type cells, bcr1A?/A? mutant cells 
can form hyphae [82]. Interestingly, bcr1A?/A? hyphal cells 
themselves are unable to adhere to surfaces and initiate 
biofilm formation. Bcr1 upregulates a number of genes 
which encode cell wall proteins, including the adhesins 
Als1, Als3, and Hwp1 [79]. It is likely therefore that hyphal 
associated cell wall composition is crucial for biofilm for-
mation. Ras1-Cyr1-PKA signalling is important in this re-
spect as it regulates the expression of adhesins, such as 
Als1, via its control of the activity of the key transcription 
factors Efg1, Tec1 and Bcr1 [79]. cAMP/PKA signalling is 
also likely to impact upon biofilm formation with respect to 
CO2 levels. For example, a local accumulation of CO2 within 
C. albicans colonies was sufficient to induce filamentous 
growth [31]. Although the precise roles have yet to be de-
termined, it will be interesting to examine how CO2 signal-
ling contributes to biofilm establishment in vivo. The final 
stage of biofilm development is the dispersal stage in 
which a mature biofilm begins ƚŽ  ‘ƚŚƌŽǁ ? ĨƌĂŐŵĞŶƚƐŽĨĨ ŝŶ
order to establish additional biofilms elsewhere [78]. The 
transcription factor Nrg1, whose degradation is inhibited 
by the C. albicans quorum sensing molecule farnesol, has 
been shown to promote biofilm cell dispersion [83]. As Ras 
activation can influence Nrg1 levels, and as farnesol has 
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been shown to promote Ras1 degradation it will be of in-
terest to investigate how Ras signalling influences the bio-
film dispersion process. 
 
RAS SIGNALLING AND VIRULENCE IN CRYPTOCOCCUS 
NEOFORMANS 
The prototypical species in the Cryptococcus genus is C. 
neoformans which is an encapsulated, pleomorphic yeast 
[84]. Similar to C. albicans, C. neoformans is an opportunis-
tic human pathogen with infection primarily being associ-
ated with a compromised immune system; cryptococcal 
infections (cryptococcosis) are a particular a problem 
amongst HIV/AIDS patients [85]. The Centers for Disease 
Control and Prevention estimates the number of deaths 
attributed to cryptococcal meningitis in HIV/AIDS patients 
is as high as 181000 per year [86].
 
C. neoformans possesses 
two RAS genes, denoted RAS1 and RAS2, which encode the 
Ras1 and Ras2 proteins respectively [87]. The Ras1 protein 
is highly conserved: it is a homolog of the traditional Ras 
proteins in mammalian cells such as H-RAS
 
[84] and has 
been demonstrated to be essential for multiple processes 
in C. neoformans including growth at 37
°
C (Ras1 is not 
needed for growth at 30
°
C), mating, agar adherence and 
filamentation [88, 89]. Due to its crucial role in these pro-
cesses, particularly thermotolerance, Ras1 is considered as 
ĂŶ ŝŵƉŽƌƚĂŶƚ ǀŝƌƵůĞŶĐĞ ĨĂĐƚŽƌ ? /ŶĚĞĞĚ ? ƚŚĞ A?ras1 mutant 
strain is avirulent in a rabbit model of cryptococcal menin-
gitis [88]. Moreover, introduction of a dominant active 
RAS1 allele (RAS1
Q67L
), which was constructed by introduc-
ing a point mutation in the active site of the GTPase do-
main of Ras1, resulted in significant increases in filamenta-
tion and agar invasion of haploid C. neoformans cells [88]. 
These are two properties which are very important for 
virulence, supporting the conclusion that Ras1 signalling is 
vital to the pathogenicity of C. neoformans. It is important 
to note that in other model systems, including Caenorhab-
ditis elegans
 
[90] and Drosophila melanogaster
 
[91], the 
A?ras1 mutant strain exhibited decreased virulence at lower 
temperatures. This implies that, at least for non-
mammalian model systems, Ras1 signalling may have sig-
nificant functions in the pathogenicity of C. neoformans 
besides thermotolerance.  
Ras signalling in C. neoformans, much like in mammalian 
cells, acts through and/or in concert with other Rho-type 
GTPases such as Cdc42 and Rac [89, 92, 93, 94, 95]. As is 
the case with RAS, C. neoformans possesses duplicate cop-
ies of CDC42 (CDC42 and CDC420)
 
[92] and RAC (RAC1 and 
RAC2) [93]. The overexpression of any of these genes over-
ĐŽŵĞƐ ƚŚĞ ƚŚĞƌŵŽƚŽůĞƌĂŶĐĞ ĚĞĨŝĐŝĞŶĐŝĞƐ ŽĨ ƚŚĞ A?ras1 mu-
tant, supporting a model whereby these GTPases act 
downstream of Ras1 (Figure 2) [89, 95]. At 37
° ? A?ras1 C. 
neoformans mutants amass a number of defects in cell 
cycle progression, specifically concerning cell polarisation 
and cytokinesis. While neither is required for viability when 
the organism is not under stress, the two Cdc42 paralogues 
are essential for septin organisation and effective cytokine-
sis at 37
°
C [92]. Ras1 is also important in the activation of 
Cdc42 and Rac [94]. Indeed, Cdc24 which is the reported 
GEF for Cdc42, undergoes a GTP-dependent physical inter-
action with Ras1 [89, 96]. Once activated, Cdc42 organises 
the septin proteins Cdc3, Cdc10, Cdc11 and Cdc12, causing 
them to localise to the bud neck ready for cytokinesis [94]. 
In addition to septin protein organisation, Ras1 signalling 
through Cdc42 is also necessary for normal bud morpholo-
gy [94]. Cdc42 appears to be the more important to C. 
neoformans virulence since it, and not Cdc420, is upregu-
lated during temperature stress and is necessary for viru-
lence in a mouse model of Cryptococcus infection [92]. As 
previously mentioned, Ras1 is not required for growth of C. 
neoformans at 30
o
C. The reason for this appears to be due 
to basal levels of Cdc42 activity even in the absence of 
Ras1 signalling which is sufficient to allow proliferation at 
this lower temperature [92, 94]. 
Although functional redundancy may exist between 
Cdc42 and Rac, the two Rac paralogues in C. neoformans 
are predominantly involved in cell polarisation and polar-
ised growth; particularly in hyphal development when mat-
ing and in the transport of vesicles during the yeast phase 
of growth [93, 95, 97] ?dŚĞA?rac1 mutant strain, while still 
able to grow at 37
o
C, displays a significant defect in haploid 
filamentation along with reduced mating [95] ? A?rac1 and 
A?rac2 mutant strains have increased yeast cell size [93], in 





[88] as well as that shown by polarity mu-
tants of the prototypical budding yeast S. cerevisiae [98]. 
This highlights the important role Ras1 signalling through 
Rac1 and Rac2 plays in cell polarity and this precisely im-
pacts hyphal development and yeast cell size.   
As with C. albicans, the ability to sense CO2 is of critical 
importance to C. neoformans. Capsule biosynthesis, which 
is a major virulence characteristic, is increased by high CO2 
levels and this is mediated by the C. neoformans adenylate 
cyclase Cac1 [20]. Importantly, it has been demonstrated 
that a fragment of CnCac1 can restore hyphal development 
in response to elevated CO2 within a cyr1A? ?A?C. albicans 
mutant. This implies the link between CO2 sensing and 
cAMP could be a general feature of pathogenic yeasts since 
C. neoformans and C. albicans are evolutionarily distantly 
related but their adenylate cyclases are functionally highly 
conserved [20].        
The C. neoformans Ras2 protein plays separable roles 
ƚŽ ƚŚŽƐĞ ŽĨ ZĂƐ ? ? &Žƌ ŝŶƐƚĂŶĐĞ ? A?ras2 cells do not exhibit 
reduced virulence in a mouse model of cryptococcosis [87]. 
&ƵƌƚŚĞƌŵŽƌĞ ? A?ras2 cells do not exhibit the same mating 
defects associated with the loss of RAS1 [87]. RAS2 is also 
found to be expressed at low levels compared to RAS1 and 
A?ras2 mutants do not display any differences in growth or 
differentiation when compared to wild-type [87].
 
However, 
it is worth noting that overexpression of RAS ? ŝŶ Ă A?ras1 
mutant is able to rescue the mating defect and partially 
restores its growth at high temperature [87]. Moreover, 
ƚŚĞ ĚŽƵďůĞ A?ras ?A?ras2 mutant has growth defects at all 
temperatures which are worse than with either single mu-
tation alone [87]. These findings suggest that Ras1 and 
Ras2 protein may have some overlapping functions in 
growth, mating and virulence that have yet to be properly 
defined. 
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TARGETING RAS TO COMBAT YEAST PATHOGENESIS 
Given its role in the virulence and pathogenic properties of 
multiple yeast (and other fungal) species, it would seem to 
have potential as anti-fungal drug target. Additionally, it 
has been shown that the manipulation of Ras signalling is 
an important control point in the activation of apoptosis in 
the budding yeast S. cerevisiae
 
[99, 100, 101] and in C. albi-
cans [102]. These findings present the possibility that the 
pharmacological manipulation of Ras signalling may be 
useful in the induction of yeast cell death. Some current 
antifungals do exert an effect on fungal Ras signalling but 
this is indirect. For example, amphotericin B inserts into 
ergosterol-containing fungal membranes to form aqueous 
pores
 
[103] which cause a local thinning of the bilayer. This 
thinning of the bilayer has been proposed to force lipid-
anchored Ras proteins into sterol-rich lipid rafts, promoting 
its interactions with downstream proteins and thus activat-
ing signalling [104]. Enhanced Ras signalling through phar-
macological manipulation induces yeast apoptosis and 
oxidative damage via the cAMP-PKA pathway, indicated by 
the fact S. cerevisiae A?ras1, A?ras2 ?A?tpk1 ?A?tpk2 ĂŶĚA?tpk3 
mutants have reduced amphotericin B-induced reactive 
oxygen species production and hence are unaffected by 
the lethal effect of amphotericin B [105]. Other fungicides 
such as miconazole and ciclopirox have been reported to 
cause fungal cell death via a similar mechanism [105].   
Ras proteins have proven difficult to directly target 
pharmacologically and because the GTPase domain is very 
highly conserved any attempt to target a fungal Ras may 
result in unfavourable side effects upon the host. Encour-
agingly a recent discovery does suggest that fungal Ras 
proteins may be targetable after all. A recent study 
demonstrated that the RasA protein of the human fungal 
pathogen Aspergillus fumigatus possesses a short N-
terminal tail domain which is missing from Ras homologs in 
higher eukaryotes [106]. This domain takes the form of a 
FIGURE 2: Ras1 signals via Cdc42 and Rac proteins to regulate many processes within the C. neoformans cell. Upon activation Ras1 
associates with Cdc24 and subsequently activates the Rho-type GTPases Rac1/Rac2 and Cdc42/Cdc420. These proteins are involved in 
multiple cellular processes such as cell cycle progression, mating and morphogenesis. 
D.R. Pentland et al. (2017)  Ras in pathogenic yeast 
 
 
OPEN ACCESS | www.microbialcell.com 70 Microbial Cell | FEBRUARY 2018 | Vol. 5 No. 2 
short length of amino acid residues which terminates in an 
arginine and has been dubbed the invariant arginine do-
main (IRD). Through sequence alignment, it has been re-
ported that the IRD is present in many different fungal 
pathogens including C. albicans and C. neoformans, as well 
as non-pathogenic fungi such as S. cerevisiae and S. pombe 
[106]. Mutation of the A. fumigatus RasA IRD decreased 
the activation of PKA as well as reducing the interaction of 
RasA with Cdc42 [106] which controls polarity and thus is 
essential for normal growth and cell division [107]. In line 
with this, mutational analyses confirmed that the IRD is 
necessary for polarised morphogenesis, a characteristic 
strongly linked with pathogenesis in A. fumigatus, and 
asexual development [106]. These findings point towards 
the possibility of designing drugs to specifically target the 
IRD as a new Ras-based pan-antifungal therapy. As an ex-
tension of this it may also be possible to target regions 
within the C-terminal variable domain of fungal Ras pro-
teins to modulate its activity.  
 
CONCLUSIONS  
Ras signalling has proven to be an important component of 
the growth and adaptability of fungal cells, as is indeed the 
case in higher eukaryotes. It is also crucial to the virulence 
and pathogenic properties of fungal species. Ras signalling 
therefore represents an interesting therapeutic target if 
fungal specific targets can be found. This may be particu-
larly effective when used in combination with other anti-
fungal agents. A full understanding of the Ras signalling 
network and its effectors will be required to achieve this 
aim. As an example, it may be possible to identify a small 
molecule that can activate fungal Ras in C. albicans. This 
may, at first glance, seem an unlikely intervention given 
the role of Ras signalling in promoting growth. However, as 
we now also know that the activation of Ras sensitizes cells 
to cell death, such an approach may prove particularly ef-
fective when used in combination with existing antifungals. 
Given the rise of antifungal resistance and our limited 
ŶƵŵďĞƌ ŽĨ ĞǆŝƐƚŝŶŐ ƚĂƌŐĞƚƐ ƐƵĐŚ  “ŬŶŽǁůĞĚŐĞ ďĂƐĞĚ ? Ăp-
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